9081333

Source:http://linkedlifedata.com/resource/pubmed/id/9081333

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0032893, umls-concept:C0205210, umls-concept:C0278996, umls-concept:C1274040, umls-concept:C1516985, umls-concept:C1522449
pubmed:issue	4
pubmed:dateCreated	1997-4-3
pubmed:language	fre
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9005324
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	0924-4212
pubmed:author	pubmed-author:BeggA CAC, pubmed-author:BernierJJ, pubmed-author:BolleAA, pubmed-author:BontempoTT, pubmed-author:CollettiPP, pubmed-author:HoriotJ CJC, pubmed-author:JancarBB, pubmed-author:Le FurRR, pubmed-author:Lopez TorrecillaDD, pubmed-author:LusinchiAA, pubmed-author:N'GuyenTT, pubmed-author:PierartMM, pubmed-author:StuschkeDD, pubmed-author:Van GlabbekeMM, pubmed-author:Van den BogaertWW, pubmed-author:Van den WeijngaertDD
pubmed:issnType	Print
pubmed:volume	83
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	314-20
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9081333-Actuarial Analysis, pubmed-meshheading:9081333-Carcinoma, Squamous Cell, pubmed-meshheading:9081333-Follow-Up Studies, pubmed-meshheading:9081333-Head and Neck Neoplasms, pubmed-meshheading:9081333-Humans, pubmed-meshheading:9081333-Neoplasm Staging, pubmed-meshheading:9081333-Oropharyngeal Neoplasms, pubmed-meshheading:9081333-Radiotherapy, pubmed-meshheading:9081333-Radiotherapy Dosage, pubmed-meshheading:9081333-Survival Rate, pubmed-meshheading:9081333-Time Factors
pubmed:year	1996
pubmed:articleTitle	[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
pubmed:affiliation	Centre Georges-François-Leclerc, Dijon, France.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III